NSC |
Compound |
Enrichment |
Correlation |
NSC 740385 |
7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide |
4.20634348588214e-005 |
0.63291909 |
NSC 747174 |
Null |
4.20634348588214e-005 |
0.47245341 |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
4.20634348588214e-005 |
0.4806751 |
NSC 123463 |
Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) |
4.2063434858822e-005 |
0.35376179 |
NSC 128571 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) |
4.2063434858822e-005 |
0.4282893 |
NSC 169774 |
Bromocriptine methanesulfonate |
4.2063434858822e-005 |
0.46727035 |
NSC 22348 |
1H-Naphth[2,3-d]imidazole-4,9-dione, 1-(p-bromophenyl)- 2-methyl- |
4.2063434858822e-005 |
0.48755412 |
NSC 628115 |
9-N(N'-chloroethyl-N'-methyl-1,2-diaminoethyl) 2 methoxyacridine dihydrochloride |
4.2063434858822e-005 |
0.54306958 |
NSC 638435 |
Null |
4.2063434858822e-005 |
0.38586133 |
NSC 672219 |
Null |
4.93279880911877e-006 |
0.36745532 |